| Gene expression patterns in ovarian carcinomas ME Schaner, DT Ross, G Ciaravino, T Sørlie, O Troyanskaya, M Diehn, ... Molecular biology of the cell 14 (11), 4376-4386, 2003 | 443 | 2003 |
| Interaction of anti-HIV protease inhibitors with the multidrug transporter P-glycoprotein (P-gp) in human cultured cells CB Washington, GE Duran, MC Man, BI Sikic, TF Blaschke JAIDS Journal of Acquired Immune Deficiency Syndromes 19 (3), 203-209, 1998 | 178 | 1998 |
| Tumor Necrosis Factor-α–Induced Protein 3 As a Putative Regulator of Nuclear Factor-κB–Mediated Resistance to O6-Alkylating Agents in Human Glioblastomas M Bredel, C Bredel, D Juric, GE Duran, RX Yu, GR Harsh, H Vogel, ... Journal of clinical oncology 24 (2), 274-287, 2006 | 169 | 2006 |
| Resistance mechanisms in human sarcoma mutants derived by single-step exposure to paclitaxel (Taxol) C Dumontet, GE Duran, KA Steger, L Beketic-Oreskovic, BI Sikic Cancer research 56 (5), 1091-1097, 1996 | 152 | 1996 |
| Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers F Moisan, EB Francisco, A Brozovic, GE Duran, YC Wang, S Chaturvedi, ... Molecular oncology 8 (7), 1231-1239, 2014 | 116 | 2014 |
| Conservation of the Class I β-Tubulin Gene in Human Populations and Lack of Mutations in Lung Cancers and Paclitaxel-resistant Ovarian Cancers S Sˇale, R Sung, P Shen, K Yu, Y Wang, GE Duran, JH Kim, T Fojo, ... Molecular cancer therapeutics 1 (3), 215-225, 2002 | 114 | 2002 |
| Novel mechanism of resistance to paclitaxel (Taxol) in human K562 leukemia cells by combined selection with PSC 833. JP Jaffrezou, C Dumontet, WB Derry, G Duran, KG Chen, E Tsuchiya, ... Oncology research 7 (10-11), 517-527, 1995 | 114 | 1995 |
| Prevalence of Multidrug Resistance Related to Activation of the mdr1 Gene in Human Sarcoma Mutants Derived by Single-Step Doxorubicin Selection G Chen, JP Jaffrézou, WH Fleming, GE Durán, BI Sikic Cancer research 54 (18), 4980-4987, 1994 | 111 | 1994 |
| Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdrl gene activation by the cyclosporin PSC 833 L Beketic-Oreskovic, GE Durán, G Chen, C Dumontet, BI Sikic JNCI: Journal of the National Cancer Institute 87 (21), 1593-1602, 1995 | 110 | 1995 |
| Multidrug-resistant human sarcoma cells with a mutant P-glycoprotein, altered phenotype, and resistance to cyclosporins G Chen, GE Durán, KA Steger, NJ Lacayo, JP Jaffrézou, C Dumontet, ... Journal of Biological Chemistry 272 (9), 5974-5982, 1997 | 103 | 1997 |
| The miR-200 family differentially regulates sensitivity to paclitaxel and carboplatin in human ovarian carcinoma OVCAR-3 and MES-OV cells A Brozovic, GE Duran, YC Wang, EB Francisco, BI Sikic Molecular oncology 9 (8), 1678-1693, 2015 | 99 | 2015 |
| Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas AK Yadav, JJ Renfrow, DM Scholtens, H Xie, GE Duran, C Bredel, ... Jama 302 (3), 276-289, 2009 | 99 | 2009 |
| Mechanisms of resistance to cabazitaxel GE Duran, YC Wang, EB Francisco, JC Rose, FJ Martinez, J Coller, ... Molecular cancer therapeutics 14 (1), 193-201, 2015 | 89 | 2015 |
| Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance JP Jaffrézou, G Chen, GE Durán, C Muller, C Bordier, G Laurent, BI Sikic, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1266 (1), 1-8, 1995 | 89 | 1995 |
| Gene expression profiling differentiates germ cell tumors from other cancers and defines subtype-specific signatures D Juric, S Sale, RA Hromas, R Yu, Y Wang, GE Duran, R Tibshirani, ... Proceedings of the National Academy of Sciences 102 (49), 17763-17768, 2005 | 85 | 2005 |
| Regional activation of chromosomal arm 7q with and without gene amplification in taxane‐selected human ovarian cancer cell lines YC Wang, D Juric, B Francisco, RX Yu, GE Duran, KG Chen, X Chen, ... Genes, Chromosomes and Cancer 45 (4), 365-374, 2006 | 71 | 2006 |
| Genetic and epigenetic modeling of the origins of multidrug-resistant cells in a human sarcoma cell line KG Chen, YC Wang, ME Schaner, B Francisco, GE Durán, D Juric, ... Cancer research 65 (20), 9388-9397, 2005 | 66 | 2005 |
| A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia JE Lancet, MR Baer, GE Duran, AF List, R Fielding, JF Marcelletti, ... Leukemia research 33 (8), 1055-1061, 2009 | 63 | 2009 |
| In vitro activity of the novel tubulin active agent BAL27862 in MDR1(+) and MDR1(−) human breast and ovarian cancer variants selected for resistance to taxanes GE Duran, H Lane, F Bachmann, BI Sikic Cancer Research 70 (8_Supplement), 4412-4412, 2010 | 60 | 2010 |
| Spontaneous overexpression of the long form of the Bcl-X protein in a highly resistant P388 leukaemia JS Kühl, S Krajewski, GE Duran, JC Reed, BI Sikic British journal of cancer 75 (2), 268-274, 1997 | 60 | 1997 |
